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Abstract
© 2018, Springer Nature Limited. Background/Objectives: Obesity is an important risk factor for
the  development  of  diseases  such  as  diabetes  mellitus,  hypertension,  and  dyslipidemia;
however, a small number of individuals with long-standing obesity do not present with these
cardiometabolic diseases. Such individuals are referred to as metabolically healthy obese (MHO)
and potentially  represent  a  subgroup  of  the  general  population  with  a  protective  genetic
predisposition  to  obesity-related  diseases.  We  hypothesized  that  individuals  who  were
metabolically  healthy,  but  significantly  obese (BMI  ≥ 35 kg/m2)  would  represent  a  highly
homogenous subgroup, with which to investigate potential genetic associations to obesity. We
further hypothesized that such a cohort may lend itself well to investigate potential genotypes
that  are  protective  with  respect  to  the  development  of  cardiometabolic  disease.
Subjects/Methods:  In  the  present  study,  we  implemented  this  novel  selection  strategy  by
screening  892  individuals  diagnosed  as  Class  2  or  Class  3  obese  and  identified  38  who
presented no manifestations of cardiometabolic disease. We then assessed these subjects for
single-nucleotide  polymorphisms  (SNPs)  that  associated  with  this  phenotype.  Results:  Our
analysis identified 89 SNPs that reach statistical significance (p < 1 × 10−5), some of which are
associated  with  genes  of  biological  pathways  that  influences  dietary  behavior;  others  are
associated with genes previously linked to obesity and cardiometabolic  disease as well  as
neuroimmune disease. This study, to the best of our knowledge, represents the first genetic
screening of a cardiometabolically healthy, but significantly obese population.
http://dx.doi.org/10.1038/s41366-018-0181-3
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